SciELO - Scientific Electronic Library Online

 
vol.74 issue2Medical vocation: need for its scientific studyCutaneous anthrax complicated by necrotizing fasciitis and compartment syndrome author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Anales de la Facultad de Medicina

Print version ISSN 1025-5583

Abstract

SOSA ROSADO, José Manuel. New oral anticoagulants in thromboembolism prevention in nonvalvular atrial fibrillation. An. Fac. med. [online]. 2013, vol.74, n.2, pp.139-144. ISSN 1025-5583.

Atrial fibrillation is the most frequent cardiac arrhythmia in clinical practice. The value of anticoagulation with vitamin K antagonists like warfarin in the prevention of embolic phenomena is widely demonstrated but managing is difficult because of its known interactions with other drugs and even food. Looking for the ideal anticoagulant in the last years new antithrombotic agents have appeared and others are in advanced phases of investigation. In the current review results of new anticoagulant agents development and expectations, opportunities and challenges are described in regards to direct thrombin and Xa factor inhibitors.

Keywords : Atrial fibrillation; warfarin; direct thrombin inhibitors; direct factor Xa inhibitors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )